Abstract: Sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) belong to a family of bioactive sphingolipids that act as important extracellular signaling molecules and chemoattractants. This study investigated the influence of S1P and C1P on the morphology, proliferation activity and osteogenic properties of rat multipotent stromal cells derived from bone marrow (BMSCs) and subcutaneous adipose tissue (ASCs). We show that S1P and C1P can influence mesenchymal stem cells (MSCs), each in a different manner. S1P stimulation promoted the formation of cellular aggregates of BMSCs and ASCs, while C1P had an effect on the regular growth pattern and expanded intercellular connections, thereby increasing the proliferative activity. Although osteogenic differentiation of MSCs was enhanced by the addition of S1P, the effectiveness of osteoblast differentiation was more evident in BMSCs, particularly when biochemical and molecular marker levels were considered. The results of the functional osteogenic differentiation assay, which includes an evaluation of the efficiency of extracellular matrix mineralization (SEM-EDX), revealed the formation of numerous mineral aggregates in BMSC cultures stimulated with S1P. Our data demonstrated that in an appropriate combination, the bioactive CELLULAR & MOLECULAR BIOLOGY LETTERS 511 sphingolipids S1P and C1P may find wide application in regenerative medicine, particularly in bone regeneration with the use of MSCs.
INTRODUCTION
Therapies based on the application of multipotent stromal cells (MSCs) are an essential part of modern regenerative medicine [1] [2] [3] [4] . In contrast to committed cells, mesenchymal stem cells possess the unique ability to self-renew and the capacity to differentiate into osteoblasts, chondrocytes and adipocytes. The nontumorigenic character of MSCs contributes to the development of pioneering strategies in medical treatment. It has also been shown that MSCs might act as pluripotent cells and express markers of endothelial cells and cardiomyocytes [5, 6] . Multipotent stromal cells isolated from various tissues, in particular from the bone marrow and adipose tissue, are increasingly considered a viable therapeutic approach in bone regeneration [7] [8] [9] [10] . Bone marrow-derived multipotent stem cells (BMSCs) and adipose stromal cells (ASCs) are readily used for clinical purposes, especially in orthopedics, due to the clinically applicable techniques for their isolation, propagation and re-implantation [1, 10, 11] . The number of clinical therapies based on MSC application has grown rapidly. Currently, MSCs are utilized in the treatment of various diseases, including Crohn's fistula and idiopathic pulmonary fibrosis (phase I of clinical trials) [12] [13] [14] . Several publications have also documented the use of autologous MSCs in the treatment of osteoarthritis [15] [16] [17] [18] . There are great expectations for therapies based on MSCs. Their immunomodulatory effect accelerates wound healing, and in consequence, provides pain relief, so that long-term hospitalization of the patient is not required [17] . Their high plasticity, reflected in the alterations of their proliferative activity and morphology, is extremely useful for the assessment of the cell biocompatibility of smart biomaterials [19] [20] [21] [22] . Maintaining a proper morphotype of MSCs with stable proliferative activity is strongly recommended, when evaluating the functionality of various active agents, both in 2D culture and in the 3D scaffolds. Bioactive agents are still being sought that would improve the proliferative potential of MSCs and thus enhance the regenerative process of damaged tissue. For these purposes, biomaterials intended for bone repair are enriched with various bioactive factors that promote self-renewal of bones and improve their functionality [23] . In terms of their clinical applications, considerable hope was associated with growth factors from the TGF-β family, i.e., bone morphogenetic proteins (BMPs) [24] . Searching for new, stable biological agents and the development of high-tech materials promoting osteoregeneration is well founded. As previously described by Ratajczak et al. [25] , membrane-derived microvesicles (MVs) released by MSCs are rich in a broad range of growth factors and cytokines, including bone morphogenetic proteins [26] . The paracrine and/or autocrine activity of MSCs provides signals that inhibit cell apoptosis and stimulate vascularization of damaged tissues [25] [26] [27] [28] [29] [30] [31] . Migration and recruitment of mesenchymal stem cells into the wound site may also be enhanced by specific chemoattractants, such as sphingolipids, which are components of the cell membranes [32] [33] [34] . Among the most important sphingolipids are sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P). S1P is synthesized by sphingosine kinase (SPHK), while C1P is a product of ceramide phosphorylation by ceramide kinase (CerK) [35] . It has recently been demonstrated that S1P controls the trafficking of osteoclast precursors (OPs) between the circulation and bone marrow cavities via G-protein-coupled receptors called S1PRs. S1PR1 mediates chemoattraction toward S1P in bone marrow, where S1P concentration is low. S1PR2 mediates chemorepulsion in the blood, where tS1P concentration is high [36] . S1PR1 activates the small G-protein Rac and induces positive chemotaxis. By contrast, S1PR2 activates another small G-protein, Rho. An active Rho protein can inhibit activation of Rac, which in turn can limit S1P-induced chemotaxis [37] . Moreover, S1P treatment highly induces S1P2, but not the S1P1 receptor protein in adipocytes. It has been shown that the S1P2 receptor is involved in S1P-mediated anti-adipogenic processes [38] . It was previously reported that OPs express S1PR2 and S1PR1, and that the positive migratory response to S1P is highly dependent on the concentration, as it is more robust at low S1P concentrations [37] . Ishii et al. [37] demonstrated that OPs express two counteracting S1P receptors: S1PR1 promotes forward movement and S1PR2 promotes backward movement. Recently, Quint et al. [39] showed that S1P stimulated mesenchymal stem cell migration by activating kinase-signaling pathways. The activation of JAK/STAT by S1PR1 and FAK/PI3K/AKT by S1PR2 signaling independently coordinated mesenchymal stem cell migration in response to S1P. These pathways seem to be activated in parallel [39] . The possible action of C1P is explained by the activation of the PI3K/PKB, MEK/ERK and JNK signaling pathways upon ligation with C1P via a putative C1P receptor [40] . However, it was demonstrated that cell migration and proliferation can only be induced when C1P is produced extracellularly and applied exogenously to the cells [41] . It was also shown that both S1P and C1P are able to regulate calcium homeostasis, and particularly S1P affects the migration of osteoblast and osteoclast precursors [42] [43] [44] . Sustained release of S1P and S1P receptor-targeted compounds from biodegradable polymer scaffolds was shown to enhance bone regeneration in cranial defects of critical size [45] . Both S1P and C1P are highly interesting to researchers due to their strong antiapoptotic properties. These two biofactors may also influence the proliferation of myoblasts and hematopoietic cells. However, this effect was stronger with C1P than with S1P [46] . It was previously shown that the expression of C1P was elevated in the bone marrow (BM) tissue that had been damaged by myeloablative treatment, and that it stimulated homing of transplanted HSPCs [47] . Because sphingolipids may affect the activity of both bone-forming and bone-resorbing cells, their role in the skeletal system homeostasis is indisputable. Osteogenesis is a multistage process. Each phase may be distinguished via specific activity of certain markers, such as cytokines, enzymes and growth factors produced locally by pre-osteoblasts, osteoblasts and osteoclasts. The analysis of several characteristic osteogenic factors, such as alkaline phosphatase (ALP), osteocalcin (OCN) and osteopontin (OPN), allows the determination of the effectiveness of osteogenesis. We were interested whether S1P and C1P could exert an effect on the morphology and osteogenic properties of multipotent stromal cells derived from the bone marrow and adipose tissue. Answering the fundamental question of the biological response of MSCs to S1P and C1P is a starting point in the development of smart biomaterials that combine the bioactive properties of both sphingolipids and MSCs. Based on our findings, we postulate that the bioactive sphingolipids can find a wide range of applications in regenerative medicine by regulating and enhancing the process of regeneration.
MATERIALS AND METHODS

Ethical approval
The experiments on animals were approved by the Second Local Ethics Committee, Chełmońskiego 38C, 51-630 Wrocław, Poland (decision No. 86/09: 84/2012).
Isolation of BMSCs and ASCs
BMSCs were isolated from adult Wistar rats. Femurs and tibias were collected directly after the animals were killed. The bones were placed in sterile Hank's balanced salt solution (HBSS). For cell collection, the heads of the bones were cut and the marrow was flushed out with HBSS into a falcon tube, followed by centrifugation for 4 min at 300 x g. ASCs were subsequently isolated from the subcutaneous fat tissue of adult Wistar rats through digestion of the fat tissue with type I collagenase (Sigma Aldrich). The details of the techniques used for BMSCs and ASCs have been described previously [22, 48] . The cultures were maintained at 37ºC in a humidified atmosphere of 5% CO 2 and 95% O 2 . The primary cultures were propagated in Dulbecco's modified Eagle's medium (DMEM, Sigma Aldrich) with Ham's F-12 nutrient. Subsequent cultures were maintained in DMEM with high glucose (Sigma Aldrich; 4500 mg/l). The media were supplemented with 10% FBS (Sigma Aldrich) and 1% antibiotics (penicillin and streptomycin; Sigma Aldrich) and changed every two days. The passage of cells was performed after they reached 80-90% confluence.
Prior to the experiment, BMSC and ASC cultures were passaged three times using trypsin solution (TrypLETM; Life Technologies) according to the manufacturers' instruction. The presence of specific antigens for BMSCs and ASCs (i.e., CD29, CD44, CD73b and CD105) was analyzed using primary antibodies (all purchased from Sigma Aldrich, except for anti-CD44, from R'n'D Systems). Hematopoietic origin was excluded by negative staining for CD45 (Sigma Aldrich). The evaluation of cell multipotency was performed by inducing cellular differentiation into bone and fat cells, respectively using MesenProOsteogenic and Adipogenic Differentiation Media (Life Technologies) for three weeks in culture. The medium was changed twice a week. After the culture, cells were fixed with 10% formalin and stained using Alizarin Red S (Sigma Aldrich) for osteogenic cultures, Oil Red O (Sigma Aldrich) for adipogenic cultures and Safranin O (Sigma Aldrich) for chondrogenic cultures.
The influence of lipids on the morphology and proliferation of BMSCs and ASCs Cells (p2) were inoculated to 24-well culture plates at a concentration of 1.5 x 10 5 cells per well. The control culture was propagated in DMEM supplemented with 10% FBS and a 1% penicillin/streptomycin solution. For the experiment, S1P dissolved in methanol was added at a concentration equal to 20 nM. The concentrations were determined according to protocol described by Calise et al. [49] . The C1P was dissolved in distilled water and sonicated for 15 min before addition to media at final concentration of 1 μM [47] . Cultures were maintained for 7 days. The morphology was analyzed using fluorescent microscopy and scanning electron microscopy (SEM) on the last day of culture. Cell proliferation was assessed using the Alamar Blue assay as described previously [50] . The metabolic activity of the cells was determined after 24, 48, 120 and 168 h of culture.
Fluorescent microscopy
For fluorescent microscopy, cells were fixed with a 4% ice-cold paraformaldehyde for 15 min, washed, and permeabilized with 0.1% Triton X-100 solution in HBSS containing 2% of FBS for 15 min at room temperature. In the next step, cells were incubated with phalloidin at to 565 nm for 30 min for F-actin staining and with DAPI for 5 min at room temperature to visualize the nuclei. After triple washing, cells were examined under an inverted epifluorescent microscope (Axio Observer.A1, Zeiss).
Evaluation of cell proliferation
In order to determine cell proliferation, the culture medium was collected and replaced with medium containing 10% of resazurin-based indicator (TOX 8, Sigma Aldrich). After 2 h of cell incubation with the dye, supernatants were collected and their absorbance was measured using a spectrophotometric plate reader (SPECTROStar Nano, BMG Labtech) at a wavelength of 600 nm and a plate background subtraction of 690 nm.
Influence of lipids on the osteogenic differentiation of BMSCs and ASCs
After the third passage, the cells were cultured in 24-well culture plates at a concentration of 1.5 x 10 5 cells per well. Osteogenic differentiation began 24 h after inoculation and lasted 21 days. During the culture, cells were maintained in the osteogenic medium (StemPro Osteogenesis Differentiation Kit, Life Technologies) supplemented with a specific phospholipid. The final concentration of sphingolipids in the culture media was 20 nM. The culture media were changed every three days. In order to determine the osteogenic properties of S1P and C1P, two control cultures were maintained simultaneously with the test. The first control consisted of cells maintained in the osteogenic medium without sphingolipids, while the cells propagated in the non-osteogenic medium (DMEM + 10% FBS and 1% of penicillin/streptomycin) served as an additional control.
Alizarin Red S staining
Alizarin Red S staining was performed to evaluate the formation of calcium deposits. Briefly, after 21 days of osteogenic differentiation, cells were fixed in 10% formalin for 1 h at room temperature, followed by washing with distilled water and incubation for 5 min in a working solution of Alizarin Red S. After that time the stain was collected and diluted tenfold, and the absorbance of alizarin red staining was measured at a wavelength of 260 nm using a nanospectrophotometer (WPA Biowave II). Afterwards, the cells were washed three times in distilled water and calcium deposits were observed under an inverted microscope (Axio Observer.A1, Zeiss). Documentation was made using a Cannon PowerShot digital camera.
Scanning electron microscopy and EDX mapping
Cells were fixed in 2.5% glutaraldehyde for 1 h, washed in distilled water, dehydrated in graded ethanol series, air dried and sputtered with gold (ScanCoat 6). The detection of mineralized matrix was performed using SEM combined with EDX (Brucker) to analyze calcium and phosphorus surface distribution. Cells were imaged using a scanning electron microscope (EVO LS15, Zeiss) at a filament tension of 10 kV, while the EDX measurements were performed at a beam accelerating tension of 20 kV.
Quantitative ALP, OCN and OPN assays
The extracellular activity of ALP was determined in the supernatants collected on the last day of experimental culture. The assay was performed using the Alkaline Phosphatase Colorimetric Assay Kit (Abcam), according to the protocol provided by the manufacturer. The experimental samples were prepared in duplicate and were diluted twofold. A background control sample was included and the background was corrected by subtracting the value derived from the zero standards from all standards, samples, and the sample of the background control. As a phosphatase substrate, p-nitrophenyl phosphate (pNPP) was used. The substrate was hydrolyzed into p-nitrophenol with alkaline phosphatase. The reaction product was measured at a wavelength of 405 nm using a microplate reader (BMGLabtech). Sample readings were applied to the standard curve to obtain the amount of pNP generated by the ALP sample. The enzymatic activity was determined using the following formula: ALP activity (U/ml) = A / V / T, where: A is the amount of pNP generated by the samples (in nmol); V is the volume of sample added to the assay well (in ml); and T is the reaction time. The OCN and OPN levels were determined in the culture supernatants collected after 21 days of culture. The medium was collected from three separate replicates. Prior to the measurements of the protein levels, the samples were thoroughly mixed. In order to determine the concentration of extracellular proteins, the Rat Gla-Osteocalcin High Sensitive ELISA Kit (Takara) and Mouse/Rat Osteopontin Quantikine ELISA Kit (R&D Systems) were used. The quantitative determination of OCN and OPN was performed according to the manufacturers' instructions. The amount of proteins detected was expressed as the ratio of protein weight to supernatant volume (w/v).
Analysis of gene expression via qRT-PCR
Cells were homogenized using TRI Reagent (Sigma Aldrich) directly in the wells. The single-step method of RNA isolation described by Chomczynski and Sacchi was used [51] . Total RNA was diluted in DEPC-treated water. The concentration and purity of the preparations were determined using a nanospectrophotometer (WPA Biowave II). In order to remove traces of genomic DNA (gDNA), samples were additionally purified using a DNase I RNase-free kit (Thermo Scientific). Each reaction was performed using 100 ng of total RNA. The resulting gDNA-free total RNA was subsequently transcribed to a complementary DNA (cDNA) using Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) and oligo (dT) 15 primers (Novazym). The procedures of RNA purification and cDNA synthesis were performed in accordance with the manufacturers' instructions. In the real-time PCR, 3 µl of cDNA was used. The sequences of the primers used for amplification of the gene are listed in Table 1 . Quantitative RT-PCR was carried out in a total volume of 20 µl using SensiFast SYBR & Fluorescein Kit (Bioline). The final concentration of primers in each reaction was 500 nM. The analysis was performed using CFX Connect Real-Time PCR Detection System (BioRad). The following cycling conditions were applied: 95ºC for 2 min, followed by 45 cycles of 95ºC for 5 s, 60ºC for 10 s, and 72ºC for 5 s with a single fluorescence measurement. An analysis of the dissociation curve of the amplicons was performed to determine the specificity of the PCR products. The melting curve was determined with the program ramped up from 65 to 95ºC at a heating rate of 0.2ºC/s and a continuous fluorescence measurement. The value of the threshold cycle (C T ) was used to calculate fold change in relation to the expression of housekeeping gene GAPDH. Each expression was calculated relative to rat GAPDH (delta C T ) and then relative to the controls (delta delta C T ) using the fluorescence threshold of the amplification reaction and the comparative C T method. 
Statistical analysis
All the quantitative results were compared with the positive control samples (pure samples) for evaluation of statistical significance using one-way ANOVA test, with statistical significance at p < 0.05.
RESULTS
Immunophenotyping of BMSCs and ASCs
The analysis of BMSC and ASC phenotypes using specific immunofluorescent staining showed that the population obtained expressed the following markers: CD29, CD44, CD73b and CD105. Both isolated MSC populations were negative for CD45, which excluded their hematopoietic origin (Fig. 1) . 
The multipotency test for BMSCs and ASCs
The BMSCs and ASCs in adipogenic cultures produced numerous lipid droplets, visualized by means of Oil Red O histochemical staining. There were no significant differences between the two analyzed cell groups ( Fig. 2A and B) .
The osteogenic differentiation of the two cell populations resulted in the deposition of calcium, which was confirmed by Alizarin Red S staining. The calcium deposits in both analyzed populations were localized mainly at the cell border regions (Fig. 2C and D) . BMSCs and ASCs induced towards chondrogenic differentiation created nodules, which contained acidic proteoglycans, which was confirmed by Safranin O staining. A higher reaction intensity and larger nodules were observed in BMSCs (Fig. 2E and F) .
The morphology and proliferation rate of BMSCs and ASCs
Both BMSCs and ASCs were characterized by a proper, fibroblast-like morphotype. Multipolar cells were prominent in all of the investigated cultures. After 7 days of propagation, BMSCs maintained in control culture did not reach full confluence, defined as a monolayer covering 80-90% of culture surface (Fig. 3C) . Although the formation of aggregates was not observed, cultures were heterogeneous, which was reflected in the presence of cells of different sizes.
A well-developed cytoskeleton was only observed in enlarged cells (white arrows, Fig. 3C, F) . The majority of the cells had centrally located nuclei (arrowhead, Fig. 3F ). Weak extracellular connections were observed in the control culture of BMSCs (Fig. 3C) . In contrast to the control culture, BMSCs propagated with the addition of S1P exhibited a regular growth pattern and extracellular space was limited, due to the elevated number of cells (Fig. 3A) . In addition, cells of comparable sizes and centrally located nuclei were predominant in the culture (Fig. 3A and D) . The addition of S1P to BMSC cultures promoted the development of extracellular connections. The most densely arranged BMSCs, at approximately 90% confluence, were observed in the culture with C1P. The propagated cells exhibited a proper growth pattern without any signs of aggregation. The actin cytoskeleton was well developed in the majority of cells and centrally located nuclei were clearly visible ( Fig. 3B and E) . The dense growth of BMSCs caused an extensive expansion of intracellular connections, especially when compared to the control culture (Fig. 3B ). Approximately 45% confluence was observed in the control culture of ASCs on the last day of the experiment. Cultured cells of various sizes and centrally located nuclei showed aggregation potential. The development of the cytoskeleton was insufficient in the majority of cells. The formation of monolayers and cell-to-cell contact was limited due to the low density of cells. The tendency of cells to aggregate was enhanced when ASC culture was supplemented with S1P ( Fig. 3G) . Moreover, cells formed multilayers in the spaces within aggregates. The expansion of the cells was maintained and the culture reached 60% confluence. In the context of cytoskeleton evaluation, we observed properly developed actin architecture. The cells investigated had centrally located nuclei (Fig. 3J) . A wide network of extracellular connections was observed within the aggregates (Fig. 3J) . Although the addition of C1P to the culture did not change the growth pattern of aggregates, the formation of the multilayer was symptomatic. After 7 days, the size of the cells was comparable with centrally localized nuclei (Fig 3K) . Furthermore, ASCs in the culture with C1P showed an affinity to contact (Fig. 3H) . The highest proliferation activity of BMSCs in the culture with S1P supplementation was observed after 24 and 120 h, while a decrease in the proliferative activity of the cells was recorded after 48 and 168 h. The proliferation rate of BMSCs propagated with the addition of C1P increased after 48 and 168 h, while a reduction in the activity of cells was detected at 24 and 120 h. The proliferation of ASCs after S1P and C1P stimulation was enhanced after 120 h. The increase in proliferation rate was maintained in the C1P culture, while in the S1P culture, proliferation was stable and comparable to the control culture (Fig. 4) . 
Alizarin Red staining, SEM imaging and EDX mapping
The SEM-EDX analysis confirmed calcium and phosphorus deposits in the osteogenic culture, while calcium and phosphorous aggregations in the nonosteogenic culture were rare. When investigating the distribution and size of membrane-derived vesicles (MVs) in the osteogenic control culture, the presence of two types of MV was observed. The size of the first type ranged between 200-450 nm and they were located in the extracellular matrix (Fig. 5 , white arrows), while the second type ranged from 400 to 1100 nm and were deposited at the bottom of mineral aggregates (Fig. 5, white arrowheads) . Evaluation of the effectiveness of osteogenesis in BMSC culture supplemented with S1P, performed using Alizarin Red staining, showed an enhanced reaction in the majority of cultures. SEM-EDX analysis revealed the presence of abundant mineral deposits, composed of calcium and phosphorous (Fig. 5, red  arrows) . Similarly to the control osteogenic culture, two distinct types of MVs were observed. The first type of MVs formed a compact layer on the surface of the cells, while the second one was accumulated in the extracellular matrix. The efficiency of the osteogenic process in BMSC cultures with C1P, determined using Alizarin Red staining, was slightly lower in comparison to the control culture. Mineral deposits, characterized by the presence of calcium and phosphorus, were uniformly distributed in the culture (Fig. 5, red arrows) . SEM observations showed the formation of a layer composed of single loose MVs (Fig. 5, white arrows) . Osteogenesis in the control ASC culture was confirmed through the presence of mineral deposits stained with Alizarin Red (Fig. 6, red arrows) . Formation of mineral deposits was not detected in the non-osteogenic culture. Mineral aggregates of similar sizes, composed of calcium and phosphorous, were observed in the osteogenic ASC control culture (Fig. 6, red arrows) . In the ASC culture, microvesicles of different sizes accumulated only on cell surfaces. MVs were not deposited into the extracellular matrix. ASCs stimulated with S1P in the osteogenic culture demonstrated a strong positive reaction when stained with Alizarin Red. SEM analysis revealed the formation of abundant mineral aggregates, which was additionally confirmed by calcium and phosphorous deposition. A compact layer of single, adherent MVs was evident, even though MVs below 200 nm were not found. Microvesicles deposited at the bottom of mineral deposits were characterized by a loose structure (Fig. 6, white arrows) . The presence of single, regular mineral deposits was detected in the osteogenic culture with C1P. SEM imaging showed that mineral deposits formed irregular larger clusters. Specific Alizarin Red staining of the BMSC osteogenic control culture, showed a positive reaction, confirming calcium deposition. No reaction to Alizarin Red was observed in the non-osteogenic culture. The osteogenesis process induced in the BMSC culture led to the formation of evenly distributed mineralized aggregates. Quantitate evaluation of Alizarin Red staining absorption revealed the highest concentration of calcium in the BMSC osteogenic culture supplemented with S1P (Fig. 7A) . Quantitate evaluation of Alizarin Red staining absorption revealed the highest concentration of calcium in the ASC osteogenic culture supplemented with S1P (Fig. 7B ).
Quantitative evaluation of the osteogenic markers osteocalcin and osteopontin and enzymatic activity of alkaline phosphatase
The quantitative analysis of OCN and OPN and the determination of ALP activity were performed on day 21 of osteogenic culture, i.e., at the late stage of osteogenesis. The level of the extracellular form of OCN was elevated in the supernatants derived from BMSC osteogenic culture, in comparison to the nonosteogenic cultures. S1P significantly increased the secretion of OCN, while C1P did not markedly affect the concentration of OCN. The level of OPN detected in the supernatants of the osteogenic culture was elevated in comparison to the non-osteogenic culture. Media collected from the osteogenic , and the activity of alkaline phosphatase (ALP; C) determined in osteogenic conditioned media after ASC and BMSC cultures with S1P and C1P. As a control, cultures under osteogenic and non-osteogenic conditions were aligned. Osteocalcin and osteopontin concentrations are shown in ng/ml, while alkaline phosphatase activity is shown in μU/ml; *p < 0.05. The results are expressed as the means of three independent experiments ± SD. OG: osteogenic, Non OG: non osteogenic.
culture with S1P showed a decrease in the concentration of OPN when compared to the control osteogenic culture. The highest concentration of OPN was determined in the supernatants after the osteogenesis of BMSCs stimulated with C1P. The highest concentration of ALP was recorded in the osteogenic control BMSC culture, whereas the activity of ALP was weak in non-osteogenic cultures. The addition of S1P to the osteogenic culture resulted in a decrease in ALP activity. The enzymatic activity of ALP was also reduced in osteogenic cultures supplemented with C1P. The activity of ALP after S1P or C1P stimulation was significantly decreased in comparison to the osteogenic control culture. An increase in the OCN concentration was observed in ASC osteogenic cultures in comparison to non-osteogenic cultures. The highest level of OCN was recorded when S1P was supplemented to the culture. The difference in the concentration of OCN between C1P and osteogenic control was negligible. The addition of S1P and C1P did not affect the concentration of OPN in the supernatants. Osteogenic differentiation in the ASC cultures also resulted in the acceleration of ALP activity in comparison to the non-osteogenic culture. There was a significant decrease in the ALP activity in the S1P-supplemented culture, while the addition of C1P resulted in an increase in ALP activity (Fig. 8) . Each expression was calculated relative to the GAPDH (delta C T ) and then relative to controls (delta delta C T ). The results are shown as the means of three experiments ± SD. Significance was determined uing Student's t-test: *p < 0.05. OG: osteogenic.
Analysis of gene expression using qRT-PCR
Actin gene expression in BMSCs cultured with the addition of S1P was at the same level as in the osteogenic control culture. The addition of C1P into BMSC culture caused a slight decrease in the actin mRNA level in comparison to the control culture, but the differences observed were statistically insignificant. The mRNA level of both OCN and OPN was significantly elevated in BMSCs propagated in the presence of S1P or C1P relative to the control culture. The expression of ALP was reduced after the addition of either S1P or C1P compared to the osteogenic control, but the observed differences were statistically insignificant. The level of actin mRNA in ASCs remained at a comparable level. The expression of OCN evaluated at the mRNA level in ASCs after S1P or C1P treatment was slightly decreased in relation to control. However, the level of OCN transcript in ASCs after C1P stimulation was higher than in ASCs after S1P treatment. The osteogenic culture of ASCs demonstrated significantly elevated expression of OPN when S1P was added to the culture. The addition of C1P resulted in a slight decline in OPN transcript expression. The level of ALP mRNA in ASCs was significantly reduced after the addition of S1P compared to the control culture as well to C1P (Fig. 9) .
DISCUSSION
Increasing evidence indicates that the bioactive sphingolipids, S1P and C1P, are involved in several biological processes. As described in the previous studies, S1P and C1P can act as anti-apoptotic agents and are strong chemoattractants affecting stromal cell migration and tissue vascularization [47, 52] . Although it is also known that other bioactive substances, e.g., growth factors from the TGF-β family, such as recombinant bone morphogenetic protein 2 (rBMP-2) may increase the osteogenic properties of the cells, their use in clinical practice, is thusfar limited. Recently, it was reported that rBMP-2 requires application of "supra-physiological" doses to induce osteogenesis [53] , and this leads to numerous adverse effects, including ectopic bone formation [3] , osteoclast activation with transiently elevated bone resorption [4] and life-threatening cervical swelling. In our in vitro study, we used 20 nM doses of the two investigated sphingolipids and we have found that both can play an important role in the enhancement of MSC osteogenic differentiation, at least when applied at that concentration. It seems that the application of S1P or C1P in future clinical trials will not require such high doses as in the case of BMP-2. While some of the molecular mechanisms of S1P and C1P function are well documented, the biological effects of their action still require further investigation, especially when osteogenesis involving the activity of MSCs is concerned. In this study, the effect of the bioactive S1P and C1P sphingolipids was investigated in multipotent stromal cells. We wanted to evaluate the morphology, growth pattern and osteogenic differentiation in MSC cultures supplemented with S1P and C1P. We used MSCs derived from bone marrow and subcutaneous adipose tissue. These are currently the most intensively investigated stem cell populations, increasingly applied in the first phase of clinical trials [54] . The results obtained in our study indicated different morphological, cytophysiological and functional responses of MSCs after stimulation with the tested chemoattractants, i.e., S1P and C1P. The cells used in our experimental model were isolated on site from rat stromal cells and characterized by analyzing the expression of the specific surface markers. The populations of MSCs were positive for CD29, CD44, CD73b and CD105 and negative for the hematopoietic marker CD45. Our aim was to comply with the recommendations of the International Society of Cellular Therapy pertaining to the characterization of human stromal cells by selected markers used for clinical applications [55] . The cells not only expressed typical stromal markers, but their morphology was also characteristic for an MSC population (fibroblast-like morphotype). We observed the most extensive actin formation when BMSCs were stimulated with C1P. By contrast, ASCs exhibited poor actin formation and an impaired growth pattern. Nevertheless, we did not observe significant differences between the level of actin mRNA expression in BMSCs and ASCs. The results obtained confirmed the stable pattern of actin mRNA expression, which additionally might serve as a housekeeping gene. S1P addition exerted varying effects on the growth pattern of MSC cultures. While BMSC cultures propagated under the influence of S1P demonstrated regular growth pattern, the ASCs exhibited the tendency to aggregate. Spontaneously formed cellular aggregates are characteristic of adipose-derived mesenchymal stem cells, especially in osteogenesis-promoting environment [56] . Although the addition of C1P into MSC cultures did not influence their morphology, a pro-proliferative effect of this agent was evident both in BMSC and ASC cultures. C1P induced in MSCs the formation of dense wellestablished extracellular connections. Moreover, the addition of C1P to ASC cultures resulted in a fewer areas with cellular aggregates compared to S1P. Cytotoxicity tests provided further evidence of the promotional effect of C1P on MSC proliferation activity. The enhancement of BMSC and ASC proliferation by C1P was particularly visible during the last day of culture, i.e., after 168 h of cell propagation. However, the proliferation rate of both MSC populations stimulated with C1P after 120 h of the experiment was decreased when compared to the control. These results are consistent with data presented by Kim et al. [47] , who demonstrated that C1P did not affect proliferation of MSCs after four days of culture. However, our results suggest that prolonged culture of MSCs in the presence of C1P results in an increased proliferation. S1P did not accelerate the proliferative potential of MSCs, when compared to the control culture. In fact, the proliferation rate of MSCs decreased after S1P supplementation to the culture environment, which is consistent with the results of the study by Schneider et al. [57] . The proliferation activity of MSCs was particularly reduced after 48 h of stimulation with S1P, even though after 168 h of culture, the proliferative activity of BMSCs and ASCs in cultures with S1P was comparable to the level for the control. A comprehensive analysis of the sphingolipids tested showed that both S1P and C1P did not exert a cytotoxic effect on MSCs. The analysis of cell morphology and nuclear organization showed no signs of apoptosis or of nuclei disorganization. The functionality assay evaluating the influence of sphingolipids on the osteogenic properties of BMSCs and ASCs was carried out at many levels. The influence of S1P and C1P on the process of MSC differentiation into the bone-forming cells (osteoblasts) lay in the area of our interests. Therefore, the analysis of biochemical and molecular markers of bone cells' activity as well as the evaluation of mineral matrix deposition were performed after 21 days of osteogenic culture, which corresponded to the late osteogenesis. The expressions of the bone-related proteins OPN and OCN were determined at the mRNA and protein levels. Additionally, we have evaluated the level of the ALP transcript, and the enzymatic activity of this protein in culture supernatants, which reflected the formation of organic matrix in the bone. Quantitative analysis of osteocalcin transcripts in BMSCs showed a higher level of mRNA after S1P treatment, which was also confirmed by quantitative analysis of protein concentration in culture supernatants. However, the addition of S1P caused a decrease in OPN secretion and ALP activity, while their mRNA levels were comparable to the control culture. Certainly, these results are influenced by the fact that both OPN and ALP are expressed in the developing bone cells during early stages of osteogenesis and prior to mineralization or osteocalcin expression [58] . The addition of C1P to the BMSC osteogenic culture did not influence the level of osteocalcin transcript expression or protein secretion when compared to the control osteogenic culture. Similarly, the level of OPN mRNA was comparable to the control, even though the secretion of OPN was significantly increased. Since osteopontin regulates the proliferation of mesenchymal stem cells, these results may serve as an additional confirmation of the pro-proliferative effect of C1P [59] . Although the transcripts of ALP remained at the level of control, the enzymatic activity of ALP was decreased. The results obtained suggest that the application of C1P to BMSC osteogenic culture enhanced the proliferative potential of osteogenic progenitor cells, while simultaneously slightly inhibiting their potential towards osteogenic differentiation. The response of ASCs to S1P stimulation caused an increase in the OCN expression level, but the mRNA was retained at a comparable level to the control culture. The final concentration of osteocalcin in both MSC supernatants indicated that S1P had a greater effect on the OCN secretion in BMSCs. The expression of OPN at the mRNA and protein level was similar to the control culture. ALP mRNA was not detected when ASCs were treated with S1P, which caused a decrease in protein activity. This result was obtained in both MSC populations and is consistent with the previous observation, showing that the ALP level starts to decline after the initial stage of osteogenesis [60] . The addition of C1P led to a decrease in OCN and OPN concentration, even though mRNA was retained at a level comparable to the control culture. Despite this, the activity of alkaline phosphatase and the transcript level have increased after C1P stimulation. This might suggest that C1P extended the early stage of ASC differentiation into osteoblasts, which would explain the elevated level of ALP on day 21 of culture.
In the last stage of our evaluation of osteogenesis of MSCs stimulated with the investigated sphingolipids, we analyzed the formation of mineralized aggregates and extracellular matrix topography. To the best of our knowledge, this is the first report providing information on the differences in matrix mineralization between BMSCs and ASCs. We have found that BMSCs produced the matrix in a different fashion. The osteogenic control culture of BMSCs, devoid of sphingolipids, synthesized and secreted two different sizes of microvesicle (MV). The first group, in the size range 200-450 nm, constituted a stromal layer for the BMSCs, while the second type were highly enriched in Ca and P, were over 450 nm in diameter, and formed a dense extracellular matrix. The extracellular matrix of ASCs was formed only from MVs of sizes above 450 nm. This strongly suggests that the analysis of matrix topography is essential when comparing osteogenic processes in BMSCs and ASCs. Therefore, these findings are crucial for the proper assessment of the influence of sphingolipids on the osteogenic properties in the current experiment. We have found that S1P stimulated the formation of mineral aggregates both in BMSCs and ASCs, but more efficient synthesis of the extracellular matrix was observed in BMSCs. The particles secreted in the BMSC osteogenic culture with S1P formed a fully developed extracellular matrix resembling a hydroxyapatite both from its morphology and chemical composition. It seems that S1P induced more mineralized aggregates and could influence the morphology of MSCs in the culture to a higher extent than C1P. The presence of C1P was also associated with a positive effect on the BMSC and ASC morphology and proliferation activity.
The results presented here shed light on how the bioactive sphingolipids can affect bone regeneration. We have shown that S1P particularly increased osteogenic differentiation of MSCs, and in consequence, may potentially enhance the bone regeneration process in vivo. To summarize our outcomes and the conclusions of other groups, both S1P and C1P may find wide application in regenerative medicine and tissue engineering, as we have demonstrated their high potential in the the regulation of MSC functions in vitro. An appropriate combination of S1P and C1P may significantly enhance the formation of functional tissue during bone regeneration. Combining the bioactive properties of both sphingolipids is within the scope of our future interests in the field of functionalized biomaterials.
